Filing Details

Accession Number:
0001140361-18-024052
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-15 18:31:21
Reporting Period:
2017-09-25
Accepted Time:
2018-05-15 18:31:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1301501 Achaogen Inc AKAO Pharmaceutical Preparations (2834) 680533693
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1700914 Lee Swem C/O Achaogen, Inc.
1 Tower Place, Suite 300
South San Francisco CA 94080
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-09-25 900 $15.99 35,919 No 4 S Direct
Common Stock Acquisiton 2018-02-08 7,730 $0.00 43,649 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2018-02-08 36,000 $0.00 36,000 $10.64
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
36,000 2028-02-08 No 4 A Direct
Footnotes
  1. The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units of the Issuer.
  2. Grant of Restricted Stock Units ("RSUs"). The reporting person is entitled to one (1) share of Common Stock for each one (1) RSU upon the vesting thereof.
  3. Includes 24,485 Restricted Stock Units.
  4. The shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of February 8, 2018, subject to the reporting person's continued employment or service relationship with the Issuer on each such vesting date.